The change of oxidative stress products in diabetes mellitus and diabetic retinopathy

British Journal of Ophthalmology

Volumn 92, Issue 4, 2008, Pages 548-551

  Pan, Hong Zhi ^a   Zhang, Hong ^a   Chang, Dong ^a   Li, Hui ^a   Sui, Hong ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADVANCED OXIDATION PROTEIN PRODUCT; ALKADIENE; CARBONYL DERIVATIVE; MALONALDEHYDE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; AGED; BLOOD PROTEINS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DNA DAMAGE; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 41849133569     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.130542     Document Type: Article

References (49)

1. Hongding Xiang. Chronic diabetic complications and related macro-vascular diseases of in-patients with diabetes in mainland of China - A national retrospective analysis in recent 10 years. Chinese J Diabetes 2003;11:232-7.
2. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-67.
3. Hinokio Y, Suzuki S, Hirai M, et al. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 1999;42:995-8.
4. Suzuki S, Hinokio Y, Komatu K, et al. Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res Clin Pract 1999;45:161-8.
5. Sano T, Umeda F, Hashimoto T, et al. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia 1998;41:1355-60.
6. den Enden MK, Nyengaard JR, Ostrow E, et al. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy. Invest Ophthalmol Vis Sci 1995;36:1675-85.
7. Ruggiero D, Lecomte M, Michoud E, et al. Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab 1997;23:30-42.
8. Armstrong D, Ueda T, Ueda T, et al. Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis 1998;2:93-104.
9. Sanchez-Thorin JC. The epidemiology of diabetes mellitus and diabetic retinopathy. Int Ophthalmol Clin 1998;38:11-18.
10. Brownlee M, Cerami A, Vlassara H. Advanced glycosylate end products in tissue and the biochemical basis of diabetic complication. N Engl J Med 1998;318:1315-21.
11. Greene DA, Lattimer SA, Sima AA. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987;316:599-606.
12. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998;47:859-66.
13. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-12.
14. Ward PA, Till GO, Hatherill JR, et al. Systemic complement activation, lung injury, and products of lipid peroxidation. J Clin Invest 1985;76:517-27.
15. Slater TF, Sawyer RC. The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used. Biochem J 1971;123:805-14.
16. Pan HZ, Chang D, Feng LG, et al. Oxidative damage to DNA and its relationship with diabetic complications. Biomed Environ Sci 2007;20:160-3.
17. Witko-Sarsat V, Friedlander M, Capelliere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-13.
18. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357-63.
19. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1-9.
20. Packer L. The role of anti-oxidative treatment in diabetes mellitus. Diabetologia 1993;36:1212-13.
21. Mehrotra S, Ling KL, Bekele Y, et al. Lipid hydroperoxide and markers of renal disease susceptibility in African-Caribbean and Caucasian patients with Type 2 diabetes mellitus. Diabet Med 2001;18:109-15.
22. Nishigaki I, Hagihara M, Tsunekawa H, et al. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 1981;25:373-8.
23. Nuttall SL, Dunne F, Kendall MJ, et al. Age-independent oxidative stress in elderly patients with non-insulin-dependent diabetes mellitus. QJM 1999;92:33-8.
24. Pagnin E, Fadini G, de Toni R, et al. Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress. J Clin Endocrinol Metab 2005;90:1130-6.
25. Devaraj S, Hirany SV, Burk RF, et al. Divergence between LDL oxidative susceptibility and urinary F2-isoprostanes as measures of oxidative stress in type 2 diabetes. Clinical Chemistry 2001;47:1974-9.
26. Bast A, Wolf G, Oberbaumer I, et al. Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia 2002;45:867-76.
27. Dursun E, Dursun B, Suleymanlar G, et al. Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus. Acta Diabetol 2005;42:123-8.
28. Polak M, Zagorski Z. Lipid peroxidation in diabetic retinopathy. Ann Univ Mariae Curie Sklodowska [Med] 2004;59:434-7.
29. Adaikalakoteswari A, Balasubramanyam M, Rema M, et al. Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with Type 2 diabetes and microangiopathy. Diabet Med 2006;23:666-74.
30. Dandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996;347:444-5.
31. Sakuraba H, Mizukami H, Yagihashi N, et al. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 2002;45:85-96.
32. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 2000;404:787-90.
33. Kaneto H, Fujii J, Suzuki K, et al. DNA clevage induced by glycation of Cu,Zn superoxide dismutase. Biochem J 1994;304:219- 25.
34. Leinonen J, Lehtimaki T, Toyokuni S, et al. New biomarker evidence of oxidative damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 2000;417:150-52.
35. Krapfenbauer K, Birnbacher R, Vierhapper H, et al. Glycoxidation, and protein and DNA oxidation in patients with diabetes mellitus. Clin Sci (Lond) 1998;95:331-7.
36. Ha H, Kim C, Son Y, et al. DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radic Biol Med 1994;16:271-4.
37. Nishikawa T, Sasahara T, Kiritoshi S, et al. Evaluation of urinary 8-hydroxydeoxyguanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 2003;26:1507-12.
38. Guerra SD, Lupi R, Marselli L, et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes 2005;54:727-35.
39. Kakimoto M, Inoguchi T, Sonta T, et al. Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial dna deletion in kidney of diabetic rats. Diabetes 2002;51:1588-95.
40. Berlett BS, Stadtman ER. Protein oxidation in aging, disease and oxidative stress. J Biol Chem 1997;272:20313-16.
41. Stadtman ER, Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev 1998;30:225-43.
42. Kalousová M, Skrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002;51:597-604.
43. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998;161:2524-32.
44. Kosova F, Cetin B, Akinci M, et al. Advanced oxidation protein products, ferrous oxidation in Xylenol Orange, and malondialdehyde levels in thyroid cancer. Ann Surg Oncol 2007;14:2616-20.
45. Cakatay U. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 2005;31:551-7.
46. Ramakrishna V, Jailkhani R. Evaluation of oxidative stress in insulin dependent diabetes mellitus (IDDM) patients. Diagn Pathol 2007;2:22.
47. Cakatay U, Kayali R. The evaluation of altered redox status in plasma and mitochondria of acute and chronic diabetic rats. Clin Biochem 2006;39:907-12.
48. Alderman Ch J, Shah S, Foreman JC. The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radical Biol Med 2002;32:377-85.
49. Loeckie LZ, Meerman JHN, Commandeur JNM. Biomarkers of free radical damage: applications in experimental animals and in humans. Free Radic Biol Med 1999;26:202-6.